63 related articles for article (PubMed ID: 27029827)
21. Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data.
Goncalves PH; Peterson SL; Vigneau FD; Shore RD; Quarshie WO; Islam K; Schwartz AG; Wozniak AJ; Gadgeel SM
Cancer; 2016 Jun; 122(12):1921-7. PubMed ID: 27062154
[TBL] [Abstract][Full Text] [Related]
22. Cerebellar function and ischemic brain lesions in migraine patients from the general population.
Koppen H; Boele HJ; Palm-Meinders IH; Koutstaal BJ; Horlings CG; Koekkoek BK; van der Geest J; Smit AE; van Buchem MA; Launer LJ; Terwindt GM; Bloem BR; Kruit MC; Ferrari MD; De Zeeuw CI
Cephalalgia; 2017 Feb; 37(2):177-190. PubMed ID: 27059879
[TBL] [Abstract][Full Text] [Related]
23. Should EGFR tyrosine kinase inhibitors be used in non-small cell lung cancer in the absence of EGFR mutations? No, EGFR TKIs should be reserved for patients with EGFR mutations.
Riely GJ
Clin Adv Hematol Oncol; 2016 Jan; 14(1):41, 44-5. PubMed ID: 27057667
[TBL] [Abstract][Full Text] [Related]
24. Erratum to: Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy.
Despierre E; Vergote I; Anderson R; Coens C; Katsaros D; Hirsch FR; Boeckx B; Varella-Garcia M; Ferrero A; Ray-Coquard I; Green JA; Steer C; Berns EM; Casado A; Lambrechts D; Jimeno A
Target Oncol; 2016 Jun; 11(3):429. PubMed ID: 27056749
[No Abstract] [Full Text] [Related]
25. The quality of diagnosis and management of migraine and tension-type headache in three social groups in Russia.
Lebedeva ER; Kobzeva NR; Gilev DV; Olesen J
Cephalalgia; 2017 Mar; 37(3):225-235. PubMed ID: 27053061
[TBL] [Abstract][Full Text] [Related]
26. GSK-3α Is a Novel Target of CREB and CREB-GSK-3α Signaling Participates in Cell Viability in Lung Cancer.
Park SA; Lee JW; Herbst RS; Koo JS
PLoS One; 2016; 11(4):e0153075. PubMed ID: 27049759
[TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literature.
Siegele BJ; Shilo K; Chao BH; Carbone DP; Zhao W; Ioffe O; Franklin WA; Edelman MJ; Aisner DL
Lung Cancer; 2016 May; 95():65-72. PubMed ID: 27040854
[TBL] [Abstract][Full Text] [Related]
28. A migraine management training program for primary care providers: An overview of a survey and pilot study findings, lessons learned, and considerations for further research.
Minen M; Shome A; Halpern A; Tishler L; Brennan KC; Loder E; Lipton R; Silbersweig D
Headache; 2016 Apr; 56(4):725-40. PubMed ID: 27037903
[TBL] [Abstract][Full Text] [Related]
29. Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.
Hedberg ML; Goh G; Chiosea SI; Bauman JE; Freilino ML; Zeng Y; Wang L; Diergaarde BB; Gooding WE; Lui VW; Herbst RS; Lifton RP; Grandis JR
J Clin Invest; 2016 Apr; 126(4):1606. PubMed ID: 27035818
[No Abstract] [Full Text] [Related]
30. Impact of Deferring Radiation Therapy in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Develop Brain Metastases.
Magnuson WJ; Yeung JT; Guillod PD; Gettinger SN; Yu JB; Chiang VL
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):673-9. PubMed ID: 27034176
[TBL] [Abstract][Full Text] [Related]
31. Cortical Spreading Depression Causes Unique Dysregulation of Inflammatory Pathways in a Transgenic Mouse Model of Migraine.
Eising E; Shyti R; 't Hoen PAC; Vijfhuizen LS; Huisman SMH; Broos LAM; Mahfouz A; Reinders MJT; Ferrari MD; Tolner EA; de Vries B; van den Maagdenberg AMJM
Mol Neurobiol; 2017 May; 54(4):2986-2996. PubMed ID: 27032388
[TBL] [Abstract][Full Text] [Related]
32. Termination of seizure clusters is related to the duration of focal seizures.
Ferastraoaru V; Schulze-Bonhage A; Lipton RB; Dümpelmann M; Legatt AD; Blumberg J; Haut SR
Epilepsia; 2016 Jun; 57(6):889-95. PubMed ID: 27030215
[TBL] [Abstract][Full Text] [Related]
33. A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives.
Sulewska A; Pilz L; Manegold C; Ramlau R; Charkiewicz R; Niklinski J
Cells; 2023 Mar; 12(6):. PubMed ID: 36980246
[TBL] [Abstract][Full Text] [Related]
34. PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma.
Kurimoto K; Hayashi M; Guerrero-Preston R; Koike M; Kanda M; Hirabayashi S; Tanabe H; Takano N; Iwata N; Niwa Y; Takami H; Kobayashi D; Tanaka C; Yamada S; Nakayama G; Sugimoto H; Fujii T; Fujiwara M; Kodera Y
Epigenetics; 2017; 12(10):865-874. PubMed ID: 29099287
[TBL] [Abstract][Full Text] [Related]
35. Pax5 Re-expression in H460 Cells Treated with the Combination of Demethylating Agent and Histone Deacetylase Inhibitor is Associated with the Enhancement of P53 Binding to Pax5 Promoter Region.
Liang Y; Zeng J; Jelicks L; Ma S; Liu J; Mei J; Perez-Soler R; Zou Y
Curr Cancer Drug Targets; 2017; 17(2):169-176. PubMed ID: 27029827
[TBL] [Abstract][Full Text] [Related]
36. Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy.
Chen MY; Liao WS; Lu Z; Bornmann WG; Hennessey V; Washington MN; Rosner GL; Yu Y; Ahmed AA; Bast RC
Cancer; 2011 Oct; 117(19):4424-38. PubMed ID: 21491416
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
38. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
39. The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells.
Zhu WG; Otterson GA
Curr Med Chem Anticancer Agents; 2003 May; 3(3):187-99. PubMed ID: 12769777
[TBL] [Abstract][Full Text] [Related]
40. HDAC as a therapeutic target for treatment of endometrial cancers.
Ren J; Zhang J; Cai H; Li Y; Zhang Y; Zhang X; Zhao D; Li Z; Ma H; Wang J; Gao YE; Xiao L; Liu R; Qian J; Liu Y; Wei H; Li J
Curr Pharm Des; 2014; 20(11):1847-56. PubMed ID: 23888962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
